feed,title,long_url,short_url
Benzinga,"FDA issues Complete Response Letter for sutimlimab, an investigational treatment for hemolysis in adults with cold agglutinin disease",https://www.benzinga.com/pressreleases/20/11/g18370196/fda-issues-complete-response-letter-for-sutimlimab-an-investigational-treatment-for-hemolysis-in-a,https://j.mp/2UncrbX
